Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis of dual-task walking in adults with dementia shows slower speed and shorter steps versus controls

Systematic review and meta-analysis of dual-task walking in adults with dementia shows slower…
Photo by Sam Jotham Sutharson / Unsplash
Key Takeaway
Consider instrumented dual-task assessments to enhance detection of cognitive-motor impairment in dementia.

This systematic review and meta-analysis examines the utility of instrumented dual-task paradigms for assessing mobility in adults with clinically defined dementia. The scope includes comparisons against single-task conditions and controls, focusing on walking outcomes such as speed, step length, and timing measures. Secondary outcomes covered balance, turning, and upper-limb performance. The review does not report a specific sample size or follow-up duration, nor does it detail adverse events or tolerability.

Key synthesized findings indicate that people with dementia walked more slowly compared with controls. Additionally, individuals with dementia took shorter steps compared with controls. Timing measures were less steady in the dementia group. Dual-task conditions generally amplified these group differences relative to single-task performance. Arithmetic loads tended to accentuate changes linked to speed and cadence, while memory and verbal fluency assessments tended to prolong timing measures.

The authors note substantial heterogeneity across studies as a primary limitation. No specific effect sizes, absolute numbers, p-values, or confidence intervals were reported for the outcomes. The review does not establish causality, and funding or conflicts of interest were not reported. Practice relevance suggests that instrumented dual-task assessments may enhance detection of cognitive-motor impairment and complement existing evaluations.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Early diagnosis of dementia may be improved by objective, scalable tests that capture how cognitive tasks interfere with movement. This study examined the use of instrumented dual-task paradigms for dementia detection and characterisation. We performed a PRISMA-guided systematic review and meta-analysis of peer-reviewed studies that used dual-task paradigms in adults with clinically defined dementia and an appropriate comparator. We extracted primary motor tasks, secondary cognitive or motor loads, sensor modalities, and analytic approaches. Walking outcomes were meta-analysed using inverse-variance weighted random-effects models, including subgroup analyses for single-task versus dual-task conditions and for arithmetic versus memory and verbal fluency assessments. The literature was dominated by cognitive-motor dual-task paradigms in Alzheimer's disease cohorts. Inertial measurement units and force plates were the most common instruments, and most studies used classical statistics, with fewer applying machine learning. Pooled effects showed consistent group differences; compared with controls, people with dementia walked more slowly, took shorter steps, and showed less steady timing. Although heterogeneity was substantial across studies, the direction of effects was stable, and dual-task conditions generally amplified group differences relative to single-task performance. Arithmetic loads tended to accentuate changes linked to speed and cadence, whereas memory and verbal fluency assessments tended to prolong timing measures. Balance, turning, and some upper-limb outcomes also differentiated groups. Instrumented dual-task assessments appear to enhance detection of cognitive-motor impairment in dementia and may complement existing evaluations. To support clinical translation, future work should extend beyond Alzheimer's disease, standardise task instructions and reporting, and evaluate multi-modal, validated analytic approaches across different dementia subtypes. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251114199, CRD420251114199.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.